Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial.
Qiang ZhouZhiqiang WangHeming WangZhidong ChenXiaoyi LiXiangrong DaiYong ZhangXiaohui YuRenpeng ZhouWei HuPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2023)
ClinicalTrials.gov identifier: NCT04627116.